Dasatinib
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Dasatinib (coding:ncit:C38713)
RxNorm: dasatinib (coding:rxcui:475342, coding:omop:1358436)
SNOMED: Dasatinib (coding:sctid:423658008, coding:omop:4307995)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (3) HC (2) | BCR::ABL1 | Chronic Myelogenous Leukemia | Dasatinib | |
| FDA (3) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Dasatinib | |
| FDA (2) HC (1) | BCR::ABL1 | Acute Lymphoid Leukemia | Dasatinib |